A comparison of the lung deposition of budesonide from Easyhlaler®, Turbuhaler® and pMDI plus spacer in asthmatic patients

Respiratory Medicine

Volumn 95, Issue 9, 2001, Pages 720-727

  Hirst, P H ^a   Bacon, R E ^a   Pitcairn, G R ^a   Silvasti, M ^b   Newman, S P ^a  

^a PHARMACEUTICAL PROFILES LTD   (United Kingdom)

^b ORION CORPORATION   (Finland)

Author keywords

Budesonide; Easyhaler ; Lung deposition; pMDI; Spacer; Turbuhaler

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; TERBUTALINE SULFATE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRY POWDER; FEMALE; GAMMA SCINTIGRAPHY; HUMAN; IN VIVO STUDY; LUNG SCINTISCANNING; MAINTENANCE THERAPY; MALE; METERED DOSE INHALER; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0034814146     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2001.1107     Document Type: Article

References (43)

1. Drug delivery to the respiratory tract using dry powder inhalers
2. Medical aerosol inhalers: Past, present and future
3. New propellant-free technologies under investigation
4. New aerosol delivery systems
5. British Guidelines on asthma management: 1995 review and position statement
6. Effect of add-on devices for aerosol drug delivery: Deposition studies and clinical aspects
7. Chlorofluorocarbon-free inhalers: Are we ready for the change?
8. Airway deposition and airway effects of antiasthma drugs delivered from metered dose inhalers
9. Scintigraphic assessment of therapeutic aerosols
10. Scintigraphic assessment of pulmonary delivery systems
11. Lung volumes and forced ventilatory flows
12. Nasal distribution of budesonide inhaled via a powder inhaler
13. Comparison of beclomethasone dipropionate delivery by Easyhaler dry powder inhaler and pMDI plus large volume spacer
14. A scintigraphic study to evaluate the deposition patterns of a novel antiasthma drug inhaled from the Cyclohaler dry powder inhaler
15. Scintigraphic assessment of drug delivery from the Ultrahaler dry powder inhaler
16. The preparation of a radiolabelled aerosol of nedocromil sodium for administration by metered dose inhaler that accurately preserves particle size distribution of the drug
17. Methods of aerosol particle size characterization
18. Particle size analysis of therapeutic aerosols
19. General tests and assays
20. Tissue attenuation corrections in gamma scintigraphy
21. Easyhaler multiple dose powder inhaler-practical and effective alternative to the pressurized MDI
22. Study of the effects of polydispersity of aerosols on regional deposition in the respiratory tract
23. Single dose comparison between a novel multiple dose powder inhaler and a conventional metered dose inhaler in asthmatic patients
24. Equivalence of two steroid-containing inhalers: Easyhaler multidose powder inhaler compared with conventional aerosol with large volume spacer
25. Patient satisfaction with Easyhaler compared with other inhalation systems in the treatment of asthma: A meta-analysis
26. Pulmonary deposition of 99mTc-labelled particles in healthy volunteers after inhalation from a metered dose inhaler and from a novel multiple-dose powder inhaler
27. Pulmonary deposition and clinical response of Tc-99m labelled salbutamol delivered from a novel multiple dose powder inhaler
28. Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler
29. Terbutaline sulphate Turbuhaler: Effect of inhaled flow rate on drug deposition and efficacy
30. The inhalation device influences lung deposition and bronchodilating effect of terbutaline
31. Total and regional lung deposition of terbutaline sulphate inhaled via a pressurised MDI or via Turbuhaler
32. Lung deposition of budesonide inhaled via Turbuhaler: A comparison with terbutaline sulphate in normal subjects
33. Lung deposition of budesonide from Turbuhaler is twice that from a pressurised metered dose inhaler p-MDI
34. Inhalation delivery of asthma drugs
35. Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurised metered dose inhaler
36. The effects of static charge in spacer devices on glucocorticosteriod aerosol deposition in asthmatic patients
37. Lung deposition of budesonide in asthmatics: A comparison of different formulations
38. Inhalation treatment with budesonide in asthma: A comparison of Turbuhaler and metered dose inhaler with Nebuhaler
39. Importance of the inhalation device on the effect of budesonide
40. Improvement in sodium cromoglycate delivery from a spacer device by use of an anti-static lining, immediate inhalation and avoiding multiple actuations of drug
41. Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children
42. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery
43. Effect of inhalation flow profiles on the deposition of radiolabelled BDP from a novel dry powder inhaler (Clickhaler), a conventional metered dose inhaler and MDI plus spacer